These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26837169)

  • 41. Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells.
    Cronauer MV; Nessler-Menardi C; Klocker H; Maly K; Hobisch A; Bartsch G; Culig Z
    Br J Cancer; 2000 Jan; 82(1):39-45. PubMed ID: 10638964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells.
    Kai L; Levenson AS
    Anticancer Res; 2011 Oct; 31(10):3323-30. PubMed ID: 21965742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Associations of saposin C, Src, and androgen receptor upregulate the expression and function of androgen receptor in human prostate cancer cells.
    Ding Y; Wang X; Xu A; Xu X; Tian K; Young CY; Yuan H
    J Cell Biochem; 2011 Mar; 112(3):818-28. PubMed ID: 21328455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteasome inhibitor PS-341 down-regulates prostate-specific antigen (PSA) and induces growth arrest and apoptosis of androgen-dependent human prostate cancer LNCaP cells.
    Ikezoe T; Yang Y; Saito T; Koeffler HP; Taguchi H
    Cancer Sci; 2004 Mar; 95(3):271-5. PubMed ID: 15016328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Augmented suppression of androgen receptor signaling by a combination of alpha-tocopheryl succinate and methylseleninic acid.
    Zhang H; Wu Y; Malewicz B; Lu J; Li S; Marshall J; Ip C; Dong Y
    Cancer; 2006 Dec; 107(12):2942-8. PubMed ID: 17120196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
    Zhang J; Li Q; Zhang S; Xu Q; Wang T
    Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Triptolide induces autophagy of ovarian granulosa cells via PI3K/AKT/m TOR pathway].
    Bai J; Wu YK; Wu KM; Zhu HL; Li N; Chen M; Liu LX
    Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3429-3434. PubMed ID: 31602905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LINE-1 ORF-1p functions as a novel androgen receptor co-activator and promotes the growth of human prostatic carcinoma cells.
    Lu Y; Feng F; Yang Y; Gao X; Cui J; Zhang C; Zhang F; Xu Z; Qv J; Wang C; Zeng Z; Zhu Y; Yang Y
    Cell Signal; 2013 Feb; 25(2):479-89. PubMed ID: 23153584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Walnut polyphenol metabolites, urolithins A and B, inhibit the expression of the prostate-specific antigen and the androgen receptor in prostate cancer cells.
    Sánchez-González C; Ciudad CJ; Noé V; Izquierdo-Pulido M
    Food Funct; 2014 Nov; 5(11):2922-30. PubMed ID: 25214070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1999 Mar; 140(3):1205-12. PubMed ID: 10067845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
    Yan J; Xie B; Capodice JL; Katz AE
    Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Triptolide affect the methylation status of HL-60cells].
    Zhang R; Ma L; Lu Y; Bai B
    Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):443-7. PubMed ID: 24857217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H
    Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic cytotoxicity of BIIB021 with triptolide through suppression of PI3K/Akt/mTOR and NF-κB signal pathways in thyroid carcinoma cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Biomed Pharmacother; 2016 Oct; 83():22-32. PubMed ID: 27470546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [PKD3 contributes to up-regulation of prostate-specific antigen in prostate cancer cells].
    Deng F; Wang CX; Xu WF; Feng L; Ke ZY; Wang QJ; Zou ZP
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1779-82. PubMed ID: 20813663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM; Frazier MC; Harris WB
    Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.